Kronos Bio, Inc. Deferred Tax Assets, Net of Valuation Allowance
Kronos Bio, Inc. had Deferred Tax Assets, Net of Valuation Allowance of $191.00 thousand as of 2024-12-31, per its 10-K filed 2025-03-18.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2025-03-18
- 2024-12-31: Deferred Tax Assets, Net of Valuation Allowance $191.00K.
- 2023-12-31: Deferred Tax Assets, Net of Valuation Allowance $3.56M.
- 2022-12-31: Deferred Tax Assets, Net of Valuation Allowance $6.61M.
- 2021-12-31: Deferred Tax Assets, Net of Valuation Allowance $7.48M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2024-12-31 | $191.00K 10-K · filed 2025-03-18 |
| 2023-12-31 | $3.56M 10-K · filed 2025-03-18 |
| 2022-12-31 | $6.61M 10-K · filed 2024-03-21 |
| 2021-12-31 | $7.48M 10-K · filed 2023-03-15 |
| 2020-12-31 | $8.39M 10-K · filed 2022-02-24 |